Veana Therapeutics Overview

  • Year Founded
  • 2012

Year Founded

  • Status
  • Private

  • Employees
  • 2

Employees

  • Latest Deal Type
  • 2ndary - Private

  • Investors
  • 9

Veana Therapeutics General Information

Description

Operator of an early clinical-stage company intended to develop oral mitochondrial inhibitors for treating various cancers. The company offers a safe and effective oral therapeutic intended to kill cancer cells selectively and is based on orally bioavailable anti-cancer agents that kill cancer cells and stimulate the immune system to boost the immunological responses in cancer patients, enabling patients to have a better quality of life during and after the treatment of cancer.

Contact Information

Ownership Status
Privately Held (backing)
Financing Status
Venture Capital-Backed
Corporate Office
  • 4640 Southwest Macadam
  • Suite 120
  • Portland, OR 97239
  • United States
+1 (503)
Primary Industry
Drug Discovery
Other Industries
Biotechnology
Corporate Office
  • 4640 Southwest Macadam
  • Suite 120
  • Portland, OR 97239
  • United States
+1 (503)

Veana Therapeutics Timeline

2023202420252026
Financing RoundCaptured Employee CountEstimated Employee Growth

Want detailed data on 11M+ companies?

What you see here scratches the surface

Request a free trial

Want to dig into this profile?

We’ll help you find what you need

Learn more

Veana Therapeutics Valuation & Funding

Deal Type Date Amount Raised to Date Post-Val Status Stage
11. Secondary Transaction - Private Completed Clinical Trials - Phase 1
10. Seed Round 19-Jun-2024 Completed Clinical Trials - Phase 1
9. Accelerator/Incubator Completed Clinical Trials - Phase 1
8. Angel (individual) 15-Jul-2023 Completed Clinical Trials - Phase 1
7. Seed Round 24-Oct-2022 Completed Clinical Trials - Phase 1
6. Grant 24-Jan-2022 Completed Pre-Clinical Trials
5. Grant 01-Aug-2021 Completed Pre-Clinical Trials
4. Seed Round 11-Nov-2020 Completed Pre-Clinical Trials
3. Grant 28-Nov-2018 $350K $9.7M Completed Pre-Clinical Trials
2. Angel (individual) 21-May-2018 $542K $9.7M Completed Pre-Clinical Trials
To view Veana Therapeutics’s complete valuation and funding history, request access »

Veana Therapeutics Cap Table

Stock # of Shares
Authorized
Par Value Dividend Rate (%) Original
Issue Price
Liquidation Liquidation
Pref. Multiple
Conversion Price % Owned
Seed 2B
Seed 2A
Seed 6,907,069 $0.000100 $0.18 $0.18 1x $0.18 9.44%
To view Veana Therapeutics’s complete cap table history, request access »

VC Exit Predictor

See how our proprietary methodology utilizes historical data sets to synthesize the likelihood of an acquisition, IPO, or no exit event. Get a detailed look at the calculations behind our predictions.

Opportunity Score

Calculated using Exit Type probabilities, the company’s stage, and PitchBook’s historical returns data.

Exit Type

Evaluates the likelihood of a successful exit for investors, and the most likely exit type.

Veana Therapeutics Signals

Growth Rate

Weekly
Growth
Weekly Growth

Size Multiple

Median
Size Multiple

Key Data Points

Similarweb Unique Visitors

Majestic Referring Domains

PitchBook’s non-financial metrics help you gauge a company’s traction and growth using web presence and social reach.

Request a free trial

Veana Therapeutics Investors (9)

Investor Name Investor Type Holding Investor Since Participating Rounds
CANCER FUND Venture Capital Minority
Alliance of Angels Angel Group Minority
Portfolia Venture Capital Minority
Business Oregon Government
National Institutes of Health Government
You’re viewing 5 of 9 investors. Get the full list »

Veana Therapeutics FAQs

  • When was Veana Therapeutics founded?

    Veana Therapeutics was founded in 2012.

  • Where is Veana Therapeutics headquartered?

    Veana Therapeutics is headquartered in Portland, OR.

  • What is the size of Veana Therapeutics?

    Veana Therapeutics has 2 total employees.

  • What industry is Veana Therapeutics in?

    Veana Therapeutics’s primary industry is Drug Discovery.

  • Is Veana Therapeutics a private or public company?

    Veana Therapeutics is a Private company.

  • What is Veana Therapeutics’s current revenue?

    The current revenue for Veana Therapeutics is .

  • How much funding has Veana Therapeutics raised over time?

    Veana Therapeutics has raised $12.6M.

  • Who are Veana Therapeutics’s investors?

    CANCER FUND, Alliance of Angels, Portfolia, Business Oregon, and National Institutes of Health are 5 of 9 investors who have invested in Veana Therapeutics.

Data Transparency

  • Meet our data hygiene team

    Discover how our experts ensure you’re getting the most accurate financial data in the industry.

    Read more
  • How PitchBook sources data

    Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.

    Discover our process